Adar Poonawalla, CEO of Serum Institute of India (SII), exuded confidence in meeting the Centre’s goal of immunising all adults by yearend, while announcing that Covid-19 vaccine for children, Covavax, is readying for a February-March launch. The Pune-based company hopes to resume exports of its vaccine, Covishield to WHObacked global platform, Covax by November. Via Times of India https://ift.tt/2hJjhqE
No comments:
Post a Comment